To test the effect of this enzyme the researchers administered small samples of inhibitor CNIO-PI3ki to obese mice over a period of five months. After two months, the mice had lost 20% of their body mass. Afterwards their weight remained stable, following a high-fat diet. Another effect was the improvement of physiological symptoms and hepatic steatosis. Elena Lopez, from CNIO, explains that steady weight loss is very dangerous in obesity cases, so it is expected to achieve an alteration in the balance between undertaking and spending of nutrient, favoring the spending of energy.
For the previously mentioned reasons and many others, we hope we can find an efficient treatment for reducing obesity among the population. Like diabetes there are many more diseases that are caused by obesity. Meanwhile we should promote the correct nutrition in the busy lifestyle of people, since malnutrition has a big effect due to the time factor.
Credits:
Images:
http://i1.wp.com/clinicadenutricionbiodieta.com/wp-content/uploads/2015/03/raton.jpg
http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/reference_guide/prescription_weight_loss_drugs_ref_guide/375x321_prescription_weight_loss_drugs_ref_guide.jpg
http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/reference_guide/prescription_weight_loss_drugs_ref_guide/375x321_prescription_weight_loss_drugs_ref_guide.jpg
No comments:
Post a Comment